MENIERE'S DISEASE
Clinical trials for MENIERE'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new MENIERE'S DISEASE trials appear
Sign up with your email to follow new studies for MENIERE'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Meniere's sufferers: drug trial targets dizziness and hearing issues
Disease control Recruiting nowThis study tests a drug called SPI-1005 in 200 adults with Meniere's disease, a condition causing dizziness, hearing loss, and ear fullness. Participants take the drug twice daily for 6 or 12 months to see if it is safe and helps control symptoms. The goal is to support long-term…
Matched conditions: MENIERE'S DISEASE
Phase: PHASE3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated May 18, 2026 03:50 UTC
-
New hope for hearing loss: drug trial targets stubborn inner ear disorders
Disease control Recruiting nowThis study tests a drug called anakinra (Kineret) in people with Meniere's disease or autoimmune inner ear disease that hasn't responded to steroids. About 57 participants will receive either anakinra or a placebo for 42 days, with follow-up over several months. The goal is to se…
Matched conditions: MENIERE'S DISEASE
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Scientists dig into DNA and blood markers to unravel Menière's mystery
Knowledge-focused Recruiting nowThis study looks at how genes and certain body chemicals (like interleukins) may play a role in Menière's disease, a condition that causes severe vertigo. Researchers will compare 250 people with Menière's disease to those with vestibular migraine and healthy volunteers. The goal…
Matched conditions: MENIERE'S DISEASE
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC